An official website of the United States government.
Date posted
Funding Agency
(Funded by the National Institutes of Health)
Researchers at Harvard University's Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Sciences have developed a new technique, called erythrocyte-leveraged chemotherapy (ELeCt), that smuggles drug-loaded nanoparticles into cancerous lung tissue by mounting them onto the body's own red blood cells (erythrocytes). When the red blood cells made it through the lungs’ tiny capillaries, the nanoparticles were taken up by lung cells with tenfold greater success than free-floating nanoparticles.
